ERBB2 and neoplasm: No significant difference was observed in terms of age, laterality, pathological tumor or nodal classification, pathological stage, hormonal receptors, the addition of chemotherapy or hormonal therapy, Her2 over-expression, surgical margin, V20 for whole lung, or chronic dermatological complications.